Dear Speaker Boehner and Minority Leader Pelosi:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our support for H.R. 5651, the Food and Drug Administration Reform Act of 2012, which includes a reauthorization of the Prescription Drug User Fee Act (PDUFA V). This bipartisan bill will incentivize the development of lifesaving therapies for patients and strengthen America’s global leadership in biomedical innovation. We commit to working with you in a collaborative fashion on remaining areas of interest in this legislation.